Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer OfferingGlobe Newswire • about 2 months ago
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM March 12, 2024 (GlobeNewswire) MDxHealth SA (NASDAQ: MDXH) (the Company or...
Share to Feed
Piper Sandler analyst Jason Bednar reiterated a Buy rating on MDxHealth (MDXH Research Report) today and set a price target of $7.00. The company...
MDxHealth (NASDAQ:MDXH Get Free Report) had its price objective hoisted by BTIG Research from $7.00 to $8.00 in a research note issued to investors on Thursday, Benzinga reports. The...
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results 2023 revenue grew by 89% to $70.2 million; excluding GPS, revenues up 42%2023 gross margin expanded by 10.7 percentage points...
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 Company to Host Conference Call with Live Q&A, March 6, 2024 at 4:30pm ET / 22:30 CET...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Mdxhealth Announces Resignation of Board Member IRVINE, CA, and HERSTAL, BELGIUM February 16, 2024 (GlobeNewswire) MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage...
MDxHealth SA (NASDAQ:MDXH Get Free Report)s stock price fell 2.5% during trading on Friday . The stock traded as low as $3.80 and last traded at $3.87. 31,450 shares were traded during...
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM January 8, 2024 (GlobeNewswire) MDxHealth SA (NASDAQ...